Galactosylceramide

Show results for

Unknown (349)
Transcriptomics (26)
Genomics (26)
Proteomics (4)
Methylation profiling (2)
Metabolomics (2)
Other (1)

Organisms

Mus musculus (21)
Homo sapiens (11)
Alphavirus (2)
Anemia (2)
Betaherpesvirinae (2)
Cowpox virus (2)
Coxsackievirus (2)
Cytomegalovirus (2)
Dengue virus (2)
EFO:0001352 (2)
Filoviridae (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus (2)
Human immunodeficiency virus 1 (2)
Human immunodeficiency virus 2 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Lyssavirus rabies (2)
Monkeypox virus (2)
Nostoc sp. PCC 7120 = FACHB-418 (2)
Oropouche virus (2)
Orthopoxvirus (2)
Orthopoxvirus vaccinia (2)
Rattus (2)
Staphylococcus aureus (2)
Streptococcus pneumoniae (2)
Bos taurus (1)

Organisms

Mus musculus (13)
Homo sapiens (5)
Rattus norvegicus (1)

Repository

ENA (23)
biostudies-arrayexpress (17)
geo (14)
MassIVE (2)
pride (2)
EGA (1)
MetaboLights (1)
MetabolomicsWorkbench (1)

Tissue

Cultured cells (1)
Blood (1)
Cell culture (1)
Oligodendrocyte (1)

Disease

Krabbe disease (1)

Technology Type

Mass Spectrometry (3)
Illumina Oncoscan Array (1)
Mass spectrometry (1)
ESI (1)
Immunopeptidomics (1)
Shotgun proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (4)
NextSeq 2000 (2)
BD FACSAria Fusion (1)
Element AVITI (1)
PromethION (1)
Affymetrix GeneChip(R) HT Scanner (1)
NextSeq 500 (1)
ACQUITY UPLC I-Class (1)
LTQ Orbitrap (1)
MS:1000031 (1)
Synapt XS (1)
Solarix (1)

Publication Date

2025 (6)
2016 (5)
2013 (5)
2026 (3)
2023 (2)
2018 (2)
2014 (2)
2012 (2)
2024 (2)
2020 (1)
2011 (1)
2022 (1)
2021 (1)
2007 (1)
2019 (1)
2017 (1)

CHEBI ID

CHEBI:134508 (1)
CHEBI:134507 (1)
CHEBI:134488 (1)
CHEBI:52254 (1)
CHEBI:134463 (1)
CHEBI:36498 (1)
CHEBI:134430 (1)
CHEBI:134245 (1)
CHEBI:134227 (1)
CHEBI:134077 (1)
CHEBI:134235 (1)
CHEBI:134234 (1)
CHEBI:88512 (1)
CHEBI:134457 (1)
CHEBI:134503 (1)
CHEBI:47766 (1)
CHEBI:134486 (1)
CHEBI:134238 (1)
CHEBI:134427 (1)
CHEBI:134266 (1)
CHEBI:134240 (1)
CHEBI:134502 (1)
CHEBI:134236 (1)
CHEBI:134028 (1)
CHEBI:75103 (1)
CHEBI:88445 (1)
CHEBI:134078 (1)
CHEBI:131145 (1)
CHEBI:134228 (1)
CHEBI:134468 (1)

Metabolite Name

1,2-distearoyl-sn-glycero-3-phosphoserine (1)
4-(trimethylammonio)butanoate (1)
Phosphatidylserine 40:9 (1)
Phosphatidylethanolamine 40:0 (1)
Phosphatidylcholine 37:0 (1)
N-[(13Z)-docosenoyl]sphing-4-enine-1-phosphocholine (1)
Phosphatidylcholine 37:1 (1)
Phosphatidylethanolamine 40:1 (1)
Monomethylphosphatidylethanolamine 36:2 (1)
Phosphatidylcholine 31:0 (1)
Phosphatidylethanolamine 34:0 (1)
Dimethylphosphatidylethanolamine 32:0 (1)
Ethyl oleate (1)
Paullinic acid (1)
Gadoleic acid (1)
5,7-icosanedione (1)
6,8-icosanedione (1)
5-methyldihydrofolic acid (1)
(6R)-5,10-methylenetetrahydrofolic acid (1)
Vaccenic acid (1)
(13Z)-octadecenoic acid (1)
Ethyl palmitoleate (1)
Apatite (1)
Lactosamine (1)
Galactosylceramide 42:2 (1)
Glucosylceramide 42:2 (1)
Phosphatidylserine 42:9 (1)
Galactosylceramide (1)
Phosphatidylcholine 35:0 (1)
Phosphatidylethanolamine 38:0 (1)

First Public Date

2024 (4)
2021 (4)
2014 (4)
2018 (2)
2016 (2)
2026 (1)
2025 (1)
2023 (1)
2022 (1)
2019 (1)
2015 (1)
2013 (1)

Study type

Transcription profiling by array (7)
RNA-seq of coding RNA (3)
Single nucleus RNA sequencing (2)
CUT&RUN (2)
Animal - One-color microarray (1)
ChIP-seq (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2019 (31)
2020 (30)
2021 (26)
2024 (25)
2023 (22)
2016 (22)
2018 (20)
2025 (19)
2014 (19)
2013 (19)
2011 (15)
2022 (15)
2015 (15)
2012 (13)
2010 (12)
2009 (10)
2017 (9)
2008 (8)
2007 (7)
2006 (6)
2026 (5)
2005 (5)
2004 (5)
2002 (2)
2000 (2)
1998 (2)
2003 (1)
1999 (1)

Lab affiliation

Cambridge Institute of Therapeutic Immunology and Infectious Diseases, Department of Medicine, University of Cambridge, (1)
VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium Department of Biomolecular Medicine, Ghent University, Ghent, Belgium (1)

Previous page
1 / 41
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 41
Next page

Sort by:

Relevance

Page size

Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via the IL-4/STAT6 signaling axis in obesity

Natural killer T (NKT) cells are important therapeutic targets in various disease models and under clinical trials for cancer patients. However, their function in obesity and type 2 diabetes remains unclear. Our data show that adipose tissues of both mice and humans contain a population of type-1 NK...

ORGANISM(S): Mus musculus

2012-04-12 | E-GEOD-36032 | biostudies-arrayexpress

Sphingomyelin modulates the transbilayer distribution of galactosylceramide in phospholipid membranes.

Not available

S-EPMC2612996 | biostudies-literature

Galactosylceramide impact on male and female Cln3Δex7/8 mouse brain gene expression

The purpose of this study is to discern global expression programs embodying therapeutic targeting of CLN3 disease. Differential gene expression in Cln3Δex7/8 mouse brains was determined after intraperitoneal vehicle/Galactosylceramide (GalCer) injections, for 40 weeks, using GeneChip Mouse Genome 4...

ORGANISM(S): Mus musculus

2020-09-11 | E-MTAB-9232 | biostudies-arrayexpress

Quantifying Beta-Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium Labeling.

Not available

S-EPMC5351000 | biostudies-literature

The PGRMC1 Antagonist AG-205 Inhibits Synthesis of Galactosylceramide and Sulfatide.

Not available

S-EPMC8700550 | biostudies-literature

Mouse iNKT cell: Wild type Vs Bcl11b deficient

Transcriptional profiling of mouse iNKT cells comparing wild type and Bcl11b deficient cell. The mice were treated with 4 Î¼g of Î±-galactosylceramide. Goal was to determine the effects of transcription factor Bcl11b removal in iNKT cells. Intraperitoneal treatment with 4 Î¼g of Î±-Galactosylceram...

ORGANISM(S): Mus musculus

2016-08-10 | E-GEOD-73679 | biostudies-arrayexpress

Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy.

Not available

S-EPMC4229631 | biostudies-literature

Time-course analysis of liver and serum galectin-3 in acute liver injury after alpha-galactosylceramide injection.

Not available

S-EPMC10852258 | biostudies-literature

Efficient synthesis of α-galactosylceramide and its C-6 modified analogs

Not available

S-EPMC9732566 | biostudies-literature

NKT TCR recognition of CD1d-α-C-galactosylceramide.